A new position has been started in Social Capital (symbol IPOB.U). The fund paid $10.20 for each unit. There is no plan to sell the stake and a strong motivation to keep adding to the position.
Social Capital's mission is "to advance humanity by solving the world’s hardest problems". Who doesn't like that mission ;)? In some seriousness, they are a driven company with an exceptional CEO (Samath Palihapitiya). The market value of the companies they invest in have yet to be quantified. KDK Fund expects this stake to keep producing positive results (financial and otherwise) for decades to come. Their website can be found here.
**All
posts on this blog are information and opinions only. They are not to
be considered recommendations to buy or sell any security. Please do
your due diligence first before trading and investing. Please direct all
questions and comments to the blog, kdkfund@gmail.com, or on
twitter @kdkfund.
Friday, May 1, 2020
1/2 Position in Microvision Sold
The fund has sold 1/2 of its position in Microvision. Some of the reasons are below.
- The price of Microvision rose to $0.40.
- Selling 1/2 the position protects capital, leaving the rest as profit
- There are other opportunities for the capital
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Saturday, April 25, 2020
Portfolio Performance (Crispr, Microvision, Hive Blockchain)
Here are some metrics and notes on the portfolio. The portfolio reflects the performance of the resources available executing the mission of KDK Fund.
Week's Notes
- Crispr Therapeutics - will likely be announcing earnings on April 27th.
- Hive Blockchain - Bitcoin halving in May 2020 (definition of halvening through Gemini Capital found here).
- Microvision - Company shareholder meeting on May 19th, 2020 (link here).
- The fund will continue to look for opportunities to improve the fund. The next likely entry into the portfolio will be energy related.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Week's Notes
- Crispr Therapeutics - will likely be announcing earnings on April 27th.
- Hive Blockchain - Bitcoin halving in May 2020 (definition of halvening through Gemini Capital found here).
- Microvision - Company shareholder meeting on May 19th, 2020 (link here).
- The fund will continue to look for opportunities to improve the fund. The next likely entry into the portfolio will be energy related.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Friday, April 17, 2020
Hive Blockchain Added to Portfolio
Hive Blockchain shares have been added to the portfolio.We currently feel that with the current resources available, this is the right move to be in the blockchain space. Hive Blockchain has the management experience, the existence in a growing market, and access to resources needed to build wealth for its stakeholders. The plan is to hold and likely add shares to the portfolio going forward.
From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate transactions on blockchain networks — like Ethereum — for rewards paid in cryptocurrencies. Everyday HIVE earns new crypto coins which it can monetize for revenue and cash flow. HIVE offers shareholders exposure to the operating margins from cryptocurrency mining plus a growing portfolio of coins.
KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's existence. The portfolio also has an equity stake in Crispr Therapeutics (post here), and Microvision (post here).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate transactions on blockchain networks — like Ethereum — for rewards paid in cryptocurrencies. Everyday HIVE earns new crypto coins which it can monetize for revenue and cash flow. HIVE offers shareholders exposure to the operating margins from cryptocurrency mining plus a growing portfolio of coins.
KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's existence. The portfolio also has an equity stake in Crispr Therapeutics (post here), and Microvision (post here).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Saturday, March 28, 2020
Microvision Added To Portfolio
Microvision shares have been added to the portfolio.
The company's focus is on using it PicoP (trademarked) technology. Our technology allows us to create high resolution miniature projection displays and LiDAR sensors.
With the amount of patents, and the value that the technology brings, we thought it would be a good speculative investment. Shares were purchased for $0.17 per share. The fund likes the Lidar technology that is pushing the automotive industry forward in self driving vehicles, which we believe will upend everything from oil to insurance to local government revenue (story here).
The portfolio looks to invest in companies that will push life's existence in a positive direction. The portfolio also has an equity stake in Crispr Therapeutics (post here).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
The company's focus is on using it PicoP (trademarked) technology. Our technology allows us to create high resolution miniature projection displays and LiDAR sensors.
With the amount of patents, and the value that the technology brings, we thought it would be a good speculative investment. Shares were purchased for $0.17 per share. The fund likes the Lidar technology that is pushing the automotive industry forward in self driving vehicles, which we believe will upend everything from oil to insurance to local government revenue (story here).
The portfolio looks to invest in companies that will push life's existence in a positive direction. The portfolio also has an equity stake in Crispr Therapeutics (post here).
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Thursday, March 26, 2020
Crispr Added to Portfolio
Crispr Therapeutics stock has been added to the portfolio. We paid $39.00 per share. The downturn in the market allowed for the shares to be in our buy zone. There is no plan to sell the shares as of now.
The company's focus is on developing transformative gene-based medicines for serious diseases. KDK Fund believes that there is still an immense amount of value to be mined from this type of research. Crspr Therapeutics is at the leading edge of this research. They have a wonderful, talented team. They have wonderful partnerships. They are in a business that is in its infancy.
The portfolio looks for investments into companies and projects that are having a positive effect on humanity's existence by expanding or creating.
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Sunday, September 29, 2019
Coming Changes to Investment Banks
by Michael Keane
A few things happened in the last couple of weeks in the IPO arena that strengthens the desire to having decentralized value more prominent. The not so wonderful feelings of fear and greed were (and are) currently present in the WeWork, Peloton, and Saudi Aramco IPO process and it hurt all three companies.
The closely guarded and deeply centralized IPO process did not work well. Conversations in the media like Sonali Basak from Bloomberg are picking up on this topic. First, the IPO of We Work was pulled with the drama of its financials and the CEO. The IPO of Peloton fell flat on its face. Some feel it got taken on the idea that the valuation is for a tech company. The government of Saudi Arabia is doing more than a few things not in its normal behavior in order to get the IPO of Saudi Aramco done. They seem to be rushing through to the IPO, ignoring the security issues as well as the stagnation and possible downward momentum in the price of oil.
One improvement may be the idea of the Dutch auction model that Google used. It just seems that there is a better deal out there for investors when it comes to IPO's. Firms not associated with the company going public like Morningstar and other analyst firms can and likely should be the driver behind how an IPO should be analyzed and sized up for investors.
Possible investors in all three companies would be served better in its goals of investment with a more visible and transparent IPO process. Sometimes, it can be a bad combination when you have private company investors looking to profit from their investment by having an IPO and investment bankers hungry for that fee. Taken separately, both are fine. But together, the above mentioned issues show up on a regular basis. If a less biased look at the company can happen, new investors, the company, and the market will be better served.
Good luck in all your trading and investing matters!
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
A few things happened in the last couple of weeks in the IPO arena that strengthens the desire to having decentralized value more prominent. The not so wonderful feelings of fear and greed were (and are) currently present in the WeWork, Peloton, and Saudi Aramco IPO process and it hurt all three companies.
The closely guarded and deeply centralized IPO process did not work well. Conversations in the media like Sonali Basak from Bloomberg are picking up on this topic. First, the IPO of We Work was pulled with the drama of its financials and the CEO. The IPO of Peloton fell flat on its face. Some feel it got taken on the idea that the valuation is for a tech company. The government of Saudi Arabia is doing more than a few things not in its normal behavior in order to get the IPO of Saudi Aramco done. They seem to be rushing through to the IPO, ignoring the security issues as well as the stagnation and possible downward momentum in the price of oil.
One improvement may be the idea of the Dutch auction model that Google used. It just seems that there is a better deal out there for investors when it comes to IPO's. Firms not associated with the company going public like Morningstar and other analyst firms can and likely should be the driver behind how an IPO should be analyzed and sized up for investors.
Possible investors in all three companies would be served better in its goals of investment with a more visible and transparent IPO process. Sometimes, it can be a bad combination when you have private company investors looking to profit from their investment by having an IPO and investment bankers hungry for that fee. Taken separately, both are fine. But together, the above mentioned issues show up on a regular basis. If a less biased look at the company can happen, new investors, the company, and the market will be better served.
Good luck in all your trading and investing matters!
**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.
Subscribe to:
Posts (Atom)